Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals

An overview of the companies with the most significant insider sells in the past week

Author's Avatar
Dec 10, 2015
Article's Main Image

According to GuruFocus Insider Data, the largest insider sells during the past week were: CDW Corp. (CDW, Financial), Twitter Inc. (TWTR, Financial), Procter & Gamble Co. (PG, Financial) and Alexion Pharmaceuticals Inc. (ALXN, Financial).

The overall trend of insiders is illustrated in the chart below:

CDW: Director Paul J. Finnegan sold 4,245,947 shares

Director Paul J. Finnegan sold 4,245,947 shares of CDW stock on Nov. 30 at the average price of $44.05. The price of the stock has decreased by 1.23% since.

CDW provides integrated IT solutions to business, government and health care customers in the United States. It has a market cap of $7.37 billion with shares traded at around $43.51 with a P/E ratio of 20.44 and a P/S ratio of 0.61. The dividend yield of CDW stocks is 0.71%. The company had an annual average earnings growth of 13.10% over the past five years.

CDW Â has released its results for the third quarter ended Sept. 30. Net sales for this quarter improved 7.2% over the prior year quarter, rising to $3.5 billion. Net income was up to $150.9 million, or 88 cents per diluted share, which compares to $55.6 million, or 32 cents per share for the same quarter last year. Adjusted EBITDA was up 16.3% to $282 million and gross profit increased 11.8% to $567 million.

Director Glenn M. Creamer also recently sold shares of CDW stock.

Twitter: Director Evan Clark Williams sold 1,885,942 shares

Director Evan Clark Williams sold 1,885,942 shares during the past week at an average price of $24.31.

Twitter has a market cap of $16.6 billion, and its shares were traded at around $24.31 with a P/S ratio of 7.94.

Twitter reported third-quarter revenue of $569 million, up 58% year over year (64% in constant currency). The company recorded GAAP net loss of $132 million and non-GAAP net income of $67 million. This compares to GAAP net loss of $175 million and non-GAAP income of $7 million in the same period of 2014. Adjusted EBITDA for the third quarter was $142 million, 108% higher than last year.

Procter & Gamble: Exec. Chairman of the Board Alan G. Lafley sold 185,000 shares

Alan G. Lafley sold 185,000 shares during the past week at an average price of $77.70.

Procter & Gamble has a market cap of $211.39 billion. Its shares were traded at around $77.70 with a P/E ratio of 30.28 and a P/S ratio of 2.99. The company has a dividend yield of 3.42% and an annual average earnings growth of 1.70% over the past 10 years.

P&G has released its fiscal first quarter 2016 results. The company reported Core EPS of 98 cents, a decrease of 1% over last year. On a currency-neutral basis, Core EPS grew 12%. Diluted EPS for the first quarter of 2016 were 91 cents, an increase of 32%. This was on net sales of $16.5 billion and operating cash flow of $3.5 billion.

Alexion Pharmaceuticals: Director Leonard Bell sold 70,000 shares

Director Leonard Bell sold 70,000 shares on Dec. 8 at an average price of $183.16.

Alexion Pharmaceuticals has a market cap of $41.27 billion. Its shares were traded at around $183.16 with a P/E ratio of 149.01 and a P/S ratio of 15.32. The company had an annual average earnings growth of 52.30% over the past five years.

For its third quarter, Alexion Pharmaceuticals reported revenues of $666.6 million, a 20% increase compared to $555.1 million for the same quarter last year. Non-GAAP diluted EPS were $1.16 compared to $1.27 for the prior year quarter. Non-GAAP R&D expenses were $146.6 million compared to $92.7 million last year.

For the complete list of stocks bought/sold by their company executives, go to: Insider Buys.